Breaking News on Global Pharmaceutical Technology & Manufacturing

Headlines > February 2016

« Previous month Next month »

Sanofi teams with University of Tokyo for drug discovery

29-Feb-2016 - Sanofi will tap Japanese academics' personalised medicine knowhow under a new collaboration with the University of Tokyo's translational research initiative (TR).


Bial cannot rule out link between BIA 10-2474 and lung lesions in study dogs

26-Feb-2016 - Bial says BIA 10-2474 met safety and tolerability requirements for human trials, but the firm cannot rule the drug out as the cause of lesions in dogs in a preclinical study....

GSK invests €12m in two new Irish API plants

26-Feb-2016 - GSK has invested €12m ($14m) into a site in Ireland to develop and manufacture ingredients for its future portolio.

Cobra Biologics and UK CPI team on AAV vector production platform

25-Feb-2016 - Cobra Biologics and the UK Centre for Process Innovation (CPI) will develop a manufacturing system for the viruses used to deliver gene therapies.

Robert Califf is new commish; Sanders still opposes

25-Feb-2016 - The US Senate has voted to support the confirmation of Robert Califf as new US Food and Drug Administration (FDA) commissioner.

Shott sets out API process development plan for former Covance lab

25-Feb-2016 - Shott Trinova has confirmed its intention to offer API production and process development at the UK laboratory it acquired Covance.

DNA 'Trojan horse' dupes drug-resistant cancer cells

25-Feb-2016 - Researchers at Ohio State University are hiding cancer drugs inside a “molecular Trojan horse” in order to successfully infiltrate drug-resistant cells.

Novartis cooperating with South Korean authorities after raid

25-Feb-2016 - Novartis has confirmed its offices in South Korea were visited by local authorities earlier this week.


Zydus Cadila given nod to export antibiotic from US FDA warned plant

24-Feb-2016 - The US FDA has given approval to Zydus Cadila to market an antibiotic made from an Indian facility hit with a Warning Letter in December.

ICIG acquires Sandoz site, expands CordenPharma’s operations

24-Feb-2016 - International Chemical Investors Group (ICIG) and Novartis Group have entered into an agreement in which ICIG will acquire all shares in Sandoz Industrial Products GmbH.

Recipharm to buy Mitim for $75m in latest Italian antibiotics sector investment

24-Feb-2016 - Recipharm will pay SEK640m ($75m) for Italian antibiotic filling specialist Mitim in a deal expected to complete later today.

Albumedix and Thiologics team up on albumin conjugation tech

24-Feb-2016 - A technology collaboration with Thiologics could increase the efficiency and yield of albumin-conjugated drugs, says Novozymes spin-out Albumedix.

News in brief

India launches online import license application portal

24-Feb-2016 - Indian drug and API importers can apply for licenses online through a new service launched by the Central Drugs Standards Control Organisation (CDSCO).

'Sponsor an excipient' campaign launched by child formulation group

24-Feb-2016 - A European project aimed at improving formulations for children is seeking industry help to develop a database on excipient safety.

Sanofi abandoning Auvi-Q after dosage problems led to total recall

23-Feb-2016 - Sanofi is poised to terminate its Auvi-Q marketing deal says PDL Biopharma, citing manufacturing issues last year which led to a complete recall of the epinephrine injection product.

Grünenthal formulates deal with Patheon for anti-abuse technology

23-Feb-2016 - Grünenthal has selected Patheon as its preferred development partner for its anti-abuse formulation platform INTAC, based on Hot Melt Extrusion (HME) technology.

Tokyo team developing stroke vaccine

23-Feb-2016 - Japanese researchers have developed a peptide vaccine with the potential to protect the brain when administered prior to a stroke, according to a study presented at the American Stroke Association’s...

Shott Trinova to add API capacity at ex-Covance animal testing site

23-Feb-2016 - ARC Trinova plans to add API process development capcity at the animal testing lab it bought from Covance.

Ciproflaxin resistance spreading says taskforce calling on drug industry for new antibiotics

22-Feb-2016 - Bacterial resistance to ciproflaxin is spreading according to the European CDC which wants the drug industry to invest in development of alternatives to the "last resort" antibiotic.

Momenta: Sandoz capable of countering Teva’s Copaxone protection strategy

22-Feb-2016 - Teva has aggressively defended its market share for its blockbuster Copaxone says Momenta, six months after marketing partner Sandoz launched the first generic version in the US.

Powder study will help safeguard $12bn Danish drug industry, say scientists

22-Feb-2016 - Research examining how API particle characteristics impact drug stability will help safeguard Denmark’s $12bn (DKK80bn) a year drug manufacturing industry say scientists.

MHRA concerned about pharma's preparedness for excipient risk assessments

22-Feb-2016 - There are concerns that pharma companies are not fully prepared to meet the new requirements on risk-assessment for excipients, even though the deadline is just a few weeks away.

ScinoPharm: expanding scope, more products in pipeline, says CEO

22-Feb-2016 - ScinoPharm Taiwan announced its unaudited financial results for fiscal year 2015, and with it, plans to expand its contract businesses through strategic acquisitions.

Qualicaps spent $43m to gain control of Brazilian capsule market, reports

18-Feb-2016 - Qualicaps has swapped a manufacturing technology customer for dominance of Brazil's fast growing pharmaceutical capsule market through a recent acquisition.

Capsugel: Pulmatrix deal brings us to ‘the forefront of inhalation delivery’

18-Feb-2016 - Capsugel has come on leaps-and-bounds since it was spun-out from Pfizer, the firm says as it inks a deal with Pulmatrix to develop inhaled therapeutics.

« Previous month Next month »

Key Industry Events


Access all events listing

Our events, Shows & Conferences...